Can you stay on 7.5mg Mounjaro instead of going higher?

The myth: you must keep going up the dose ladder

A common assumption is that Mounjaro only "works" at the top end (10mg, 12.5mg, 15mg) and that pausing at 7.5mg means settling for a lesser outcome. That picture is incomplete. The titration schedule described in the Mounjaro Summary of Product Characteristics on the eMC is designed primarily around tolerability: starting at 2.5mg gives the body time to adjust before the dose that does most of the therapeutic work is reached. There is no rule that says every patient must reach 15mg. Some people lose significant weight at 7.5mg. Some find that gastrointestinal side effects become harder to manage above that level. Others are progressing steadily and their prescriber simply sees no clinical reason to change something that is already working. The idea that a "real" course of Mounjaro must end at the ceiling dose is a myth worth correcting at the start, because it leads some people to push for increases they do not need and others to feel they have somehow fallen short by not doing so.

If you are wondering whether you can stay on 7.5mg Mounjaro long term, the honest answer is that it depends on your individual response, and that is exactly the kind of question a good clinical review is designed to address.

What your prescriber is actually weighing up

When a prescriber considers whether to hold you at 7.5mg, they are looking at a few things together. First, weight loss trajectory: is the treatment still producing measurable progress? Second, side-effect burden: are gastrointestinal symptoms (nausea, loose stools, reduced appetite) at a level that is tolerable and has settled, or are they still significant enough that increasing the dose would make daily life difficult? Third, your own goals and any relevant health background.

The NICE technology appraisal for tirzepatide (TA1026) notes that treatment should be reviewed if weight loss is less than 5% after six months at the highest tolerated dose, the phrase "highest tolerated" is doing real work there. It explicitly acknowledges that not every patient will reach 15mg, and that tolerability shapes dose decisions. A prescriber supporting a 7.5mg hold is following that principle, not bending it. If you keep a pen in the fridge door and have settled into a routine that is working, that consistency itself has value, disrupting it with an unnecessary increase can set things back.

For context on how earlier dose decisions are made, our page on staying on 5mg Mounjaro covers the same framework at a lower starting point.

Side effects and the case for holding steady

One of the most practical reasons to stay on 7.5mg is side-effect management. Mounjaro's most common effects are gastrointestinal (nausea, indigestion, changes in bowel habit) and they tend to be dose-dependent. Many people find that these settle after a few weeks at a new dose, but for some individuals moving to 10mg brings a second wave of symptoms that outweighs the benefit. Holding at 7.5mg avoids that reset.

The NHS patient information for tirzepatide on nhs.uk lists these gastrointestinal effects as common, notes they are usually mild to moderate, and advises contacting your prescriber if they are severe or persistent. That guidance applies at every dose step, including the move from 7.5mg to 10mg. If you are experiencing manageable effects at 7.5mg that you expect to worsen with an increase, that is a reasonable clinical conversation to have, not a reluctance to engage with treatment. Our Mounjaro treatment overview covers the full side-effect picture in more detail.

A question our prescribers hear regularly is whether slowing or pausing titration has any lasting downside. In most cases, no, the medicine continues working at the dose you are on, and a slower path to a higher dose (if that is eventually the right step) is simply a more cautious route rather than a failed one.

How to have this conversation with your prescriber

The most productive approach is to come to your clinical review with specifics: how much weight you have lost since starting or since your last dose change, what side effects you have experienced and how they have changed over time, and what your own preference is. Prescribers are not trying to push patients to the highest dose for its own sake. Clinical review at every repeat order (which is how treatment works at a regulated service like ours) is precisely the opportunity to make this case.

If you are weighing up the broader picture of staying on a lower dose of Mounjaro generally, that page sets out the principles that apply across the dose range, and if you are earlier in your journey and curious about whether staying on 2.5mg Mounjaro is an option, that page applies the same thinking to the starting dose. And if cost is part of your thinking, our Mounjaro cost page explains what is included in a private prescription and how pricing is structured, worth reading alongside dose decisions, since staying at 7.5mg rather than moving up does affect what you pay per month. Check your eligibility to speak with one of our prescribers about where you are in your treatment.